Alkemist Labs announces expansion of its services
Alkemist Labs has added microbiological and residual solvents testing as well as testing for THC analogs such as delta 8 & 10, Astaxanthin esters, and lower limits of detection for heavy metals.
Photo © iStockphoto.com/nicolas_
Alkemist Labs (Garden Grove, CA) has announced the expansion of its suite of services which now includes microbiological and residual solvents testing. This is on top of pesticides and heavy metals testing launched in March of 2022. The company has also added testing for THC analogs such as delta 8 & 10, Astaxanthin esters, and lower limits of detection for heavy metals.
The new services, with the exception of astaxanthin, are included in Alkemist Labs’ A2LA ISO 17025 scope of accreditation (3851.01), which has just been renewed through February 2026. Its other accredited services including Identification by HPTLC, Identification by microscopy, Cannabinoids quantification by HPLC, Terpenes content by GC-FID, and Pesticides content by LC-MS/GC-MS/MS have also been renewed through February 2026. Its psychedelic testing services has been added to the ISO scope as well.
“For years clients have said they wished Alkemist could meet all their testing needs so they could be as confident in all aspects of testing as they are in botanical and fungal identity, and we heard them,” said Alkemist Labs CEO Elan Sudberg, in a press release. “Although it takes time to acquire new instrumentation, develop and validate test methods, and then get all that included in our ISO accreditation, this is a great achievement. I’m proud of the Alkemist staff for this expansion, and excited to meet our clients’ needs in so many new areas.”
Learn more about Alkemist Labs’ testing methods and new services here.
Kaneka Nutrients to unveil new consumer research on menopausal women at Vitafoods Europe 2024
April 26th 2024The company will reveal the results of the research that is based on live feedback from 200 menopausal women who took 200 mg per day of Kaneka Ubiquinol over two-months, monitored the effects, and recorded their observations.
Rousselot to showcase new collagen peptide research and targeted solutions at Vitafoods Europe 2024
April 25th 2024The company will be highlighting new research that demonstrates the ability of its Peptan collagen peptide brand to support sleep quality, reduce gastrointestinal discomfort, and enhance skin health, including density, hydration, and elasticity.
